Accretion vs. Dilution: The Math of a Good Deal

TL;DR: When a CEO announces a merger, the first thing Wall Street asks is: "Is it Accretive?" An Accretive deal is one that makes the Earnings Per Share (EPS) of the combined company go UP. A Dilutive deal is one that makes the EPS go DOWN. It is the ultimate "Profitability Test" for a merger. If a deal is dilutive, it means the CEO is overpaying or the new company is too weak, leading to a crash in the stock price the moment the deal is announced.

Introduction: The "EPS" Ruler

In the stock market, "Total Profit" doesn't matter. What matters is Earnings Per Share (EPS)—how much profit each individual share represents.

If a company buys another company, they are adding more profit, but they are also adding more shares (if they pay with stock) or more interest costs (if they pay with debt).

The Accretion/Dilution Analysis is the mathematical formula used by investment bankers to see if the "New Profit" is larger than the "New Cost."

1. Accretion (The "Winning" Deal)

A deal is Accretive when the combined entity is more profitable per share than the original company was alone.

• The Logic: You buy a company for $100 Million. That company brings in $20 Million in profit. The cost to buy them (interest + new shares) is only $15 Million.
• The Result: You have "Found" $5 Million in extra value for your shareholders. Your EPS goes from $1.00 to $1.05.
• The Market Reaction: Investors love accretion. The stock price usually rises because the company is now more "efficient."

2. Dilution (The "Overpaid" Deal)

A deal is Dilutive when the merger actually reduces the value of each existing share.

• The Logic: You buy a "hot" startup for a massive price. You print millions of new shares to pay for it. The startup's profit is tiny compared to the number of new shares you just created.
• The Result: Your EPS drops from $1.00 to $0.90. You have "diluted" your own shareholders' ownership of the profit.
• The Market Reaction: Investors hate dilution. They view it as the CEO "Empire Building"—spending shareholder money to make the company bigger without making it better.

The "Synergy" Hallucination

To turn a Dilutive deal into an Accretive one (on paper), CEOs use Synergies. They tell Wall Street: "Yes, the math looks bad now, but we will fire 2,000 people and close 50 factories. This will save us $200 Million a year. Once you add those 'Synergies,' the deal becomes Accretive!"

Wall Street is skeptical of synergies because they are often "hallucinations" that never actually happen. Many of the worst mergers in history (like AOL/Time Warner) were sold to the public as "highly accretive" based on fake synergies.

The "Price-to-Earnings" (P/E) Magic

There is a simple rule of thumb in this math:

• If you have a High P/E (the market thinks you are a "Star") and you buy a company with a Low P/E (the market thinks they are "Boring"), the deal is almost always Accretive.
• This is why tech giants like Microsoft and Google love buying boring, profitable hardware or software companies—they can use their "Expensive" stock to buy "Cheap" earnings.

Conclusion

An Accretion/Dilution analysis is the "Truth Serum" of M&A. It proves that a merger is not just a strategic vision; it is a mathematical calculation. By stripping away the PR hype and focusing on the cold reality of Earnings Per Share, this analysis ensures that shareholders can distinguish between a deal that creates real wealth and a deal that is merely a multi-billion dollar ego project for the CEO. 引导语：增厚/摊薄分析（Accretion/Dilution analysis）是并购中的“真理血清”。它证明了，一场合并不仅是一个战略愿景，更是一个数学计算。通过剥离公关炒作，专注于每股收益的冷酷现实，这种分析确保了股东能够区分真正创造财富的交易和仅仅是首席执行官价值数十亿美元的自尊心项目。